July 14th, 2025
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a company operating at the convergence of TechBio and biological intelligence, today announced that it has received formal notification from...